Repotrectinib in a Patient With NTRK Fusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome.
Karen M YunAnna NarezkinaCharles RedfernKatherine VelascoLyudmila BazhenovaPublished in: JCO precision oncology (2024)
Repotrectinib in a patient with NTRK fusion-positive pancreatic carcinoma and congenital long QT syndrome.
Keyphrases